M11.069
Hydroxyapatite deposition disease, unspecified knee
Clinical Classification Guidelines
Medical Intelligence & Overview
Hydroxyapatite deposition disease (HADD) in the knee is a condition characterized by the abnormal accumulation of hydroxyapatite crystals within the soft tissues surrounding the knee joint. These deposits can cause inflammation, pain, and reduced mobility. While often occurring in tendons or bursae near the joint, the exact cause of this condition remains unclear. It primarily affects middle-aged and older adults and can significantly impact daily activities if left untreated.
Causes & Symptoms
Clinical Causes: Degeneration of tendons or cartilage associated with aging Repetitive stress or overuse of the knee joint Previous injuries or trauma to the knee Genetic predisposition in some individuals Metabolic disorders, such as calcium metabolism abnormalities Chronic joint inflammation or degenerative changes
Key Symptoms: Localized pain around the front or sides of the knee Swelling and tenderness in the affected area Reduced range of motion or stiffness Able to feel or see small, firm lumps near the joint Pain that worsens with movement or pressure Occasional warmth or redness over the affected area
Diagnostic & Treatment
Diagnosis Path: Diagnosis of hydroxyapatite deposition disease involves a combination of clinical evaluation and imaging techniques. Healthcare providers typically begin with a physical examination to assess tenderness, swelling, and range of motion. Imaging studies such as X-rays are crucial, often revealing calcified deposits characteristic of HADD. In some cases, ultrasound or MRI scans might be used to visualize soft tissue changes and confirm the presence of calcium deposits. Laboratory tests are usually not necessary but may be performed to rule out other conditions.
Treatment Protocols: Management of HADD in the knee aims to relieve symptoms and promote healing. Common approaches include: - Rest and activity modification to reduce strain on the knee - Application of ice packs to decrease inflammation and pain - Nonsteroidal anti-inflammatory drugs (NSAIDs) for pain relief - Physical therapy exercises to maintain joint flexibility and strength - In some cases, corticosteroid injections can be administered to reduce severe inflammation - Ultrasound-guided needling or lavage may be used to remove calcified deposits - Surgical removal of deposits is considered when symptoms persist despite conservative treatment Most cases resolve with conservative measures, but ongoing management may be required to prevent recurrence.
Clinical Advice & FAQs
Billing Guidance
Is M11.069 a billable ICD-10 code?
Yes, M11.069 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M11.069?
Clinical documentation must specify the nature of Hydroxyapatite deposition disease, unspecified knee and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
